ACT Genomics Hong Kong office was established in January 2017 to meet the growing cancer needs in Hong Kong. The Next Generation Sequencing (NGS) laboratory at Hong Kong Science Park was opened in July 2019 to provide better support in the region. In Hong Kong, there were 33,075 new cancer cases diagnosed in 2017, which increased 2.8% annually according to The Hong Kong Cancer Registry. The top 5 cancers in 2017 were colorectal cancer (17%), lung cancer (15.7%), breast cancer (13.3%), prostate cancer (6.8%), and liver cancer (5.5%). We are a team of experts with years of experience in oncology, cancer genomics and bioinformatics; aiming to provide treatment guidance and disease monitoring with better precision for cancer patients.
Patients Education Video
Precision Medicine - How Genomic Profiling Chooses Drugs For Patients
ACT Genomics' cancer genomic prifiling services can bring solid tumor patients many treatment opportunities.
Video Clip : How cancer genomic profiling help treatment
Genomic profiling & cancer treatment- Basic understanding
Recent Events
2019.10.26 & 27 The 6th Hong Kong International Oncology Symposium
The 6th Hong Kong International Oncology Symposium was held on October 26 & 27, 2019 and featured a series of presentations by experts in the field. The symposium was hosted by Hong Kong Precision Oncology Society(HKPOS), and sponsored by ACT Genomics. Click on the link below to enter the symposium page .
Entrance of The 6th HKIOS page
2019.07.04 & 24 ACT Genomics Hong Kong Lab Grand Opening
ACT Genomics opened its third Next Generation Sequencing laboratory in Asia at the Hong Kong Science Park on July 4, 2019. Cocktail reception and lab tour were held on July 24.
ACT Genomics Hong Kong Lab Grand Opening
ACT Genomics Hong Kong Lab Cocktail Reception & Lab Tour
2019.06.29 Precision Treatment for Lung Cancer Patients Symposium
Precision Treatment for Lung Cancer Patients Symposium was held on June 29, 2019 and featured a series of presentations by experts in the field. The symposium was hosted by Hong Kong Precision Oncology Society(HKPOS), and sponsored by ACT Genomics.
Dr. Shu Jen Chen on "Biomarkers in Drug Selection for Lung Cancer Treatment"
Dr. Jacky Yu-Chung Li on "Targeted Treatment for Lung Cancer"
Dr. Chun-Ming Tsai on "Clinical Application of NGS in lung cancer management"
Event Highlights of Precision Treatment for Lung Cancer Patients Symposium
2018.10.10 The 5th Hong Kong International Oncology Symposium
The 5th Hong Kong International Oncology Symposium was held on October 10, 2018 and featured a series of presentations by experts in the field. The symposium was hosted by Hong Kong Precision Oncology Society(HKPOS), and sponsored by ACT Genomics.
Event Highlights of The 5th Hong Kong International Oncology Symposium
2017.09.21 Precision Oncology Symposium Session III: Lung Cancer
Precision Oncology Symposium Session III: Lung Cancer was held on September 21, 2017 and featured a series of presentations by experts in the field. The symposium was hosted by Hong Kong Lung Cancer Study Group (HKLCSG), and sponsored by ACT Genomics.
Full Version - 2017 Precision Oncology Symposium - Lung Cancer - Hong Kong
Dr. Jacky Yu-Chung Li on "Go Beyond Resistance"
Dr. Shu Jen Chen on "Clinical Application of NGS on Lung Cancer Management"
Q&A Session - Lung Cancer
2017.06.15 Precision Oncology Symposium Session II: Colorectal Cancer
Precision Oncology Symposium Session II: Colorectal Cancer was held on June 15, 2017 and featured a series of presentations by experts in the field. The symposium was hosted by Hong Kong College Of Radiologists and Hong Kong Society of Clinical Oncology, and sponsored by ACT Genomics.
2017 Precision Oncology Symposium - Colorectal Cancer in Hong Kong
Dr. Chi Leung Chiang on "Management of Metastatic Colorectal Cancer (mCRC)"
Dr. Siu-Kie Au on "Molecular Classification of Colorectal Cancer"
Dr. Jensen Poon on "Surgical Management of Colorectal Cancer"
Dr. Shu Jen Chen on "NGS and Precision Management of Colorectal Cancer"
Q&A Session - Colorectal Cancer
2017.05.10 Precision Oncology Symposium Session I: Breast Cancer
Hosted by the Hong Kong Breast Oncology Group and ACT Genomics, Precision Oncology Symposium Session I: Breast Cancer was held on May 10, 2017 and featured a series of presentations by experts in the field.
Event Highlights of Breast Cancer Precision Oncology Symposium
Dr. Lorraine Chow on "Surgical Management of Breast Cancer"
Dr. Joseph Au on "Genomics Assay and Adjuvant Treatment Decision-Making"
Dr. Janice Tsang on "Targeted Therapies for Breast Cancer"
Dr. Shu Jen Chen on "NGS Application for Management of Breast Cancer"
Welcome to ACT Genomics Hong Kong
Contact
To find out more about our services, get in touch with us at
ACT Genomics Hong Kong
Tel: +852 2186 9600
Fax: +852 2186 9699
Office: Units 803 – 807, 8F, Building 15W, No.15 Science Park West Avenue, Hong Kong Science Park, Pak Shek Kok. NT, Hong Kong